Five things to know:
1. Medtronic’s revenue grew 4.1 percent year-over-year on an organic basis, according to a news release.
2. Cranial and spinal technologies raked in $1.1 billion, a 2.8 percent increase compared to the same time last year. Medtronic’s spine biologics saw low growth, and the neurosurgery segment saw high-single digit growth.
3. The robotics, navigation, imaging and powered surgical instruments segment saw double-digit growth year-over-year.
4. Medtronic’s cardiovascular portfolio brought in $2.8 billion, a 1 percent increase year-over-year.
5. The company increased its outlook for fiscal year 2023 and expects fourth quarter revenue growth of 4.5 percent to 5 percent.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
